Date Filed | Type | Description |
08/02/2023 |
4
| Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.
Txns:
| Granted 126 shares
@ $2.81, valued at
$354.1 |
|
02/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/02/2023 |
4
| Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.
Txns:
| Granted 1,938 shares
@ $10.2085, valued at
$19.8k
Paid exercise price by delivering 7,658 shares
@ $13.78, valued at
$105.5k
Exercised 16,546 restricted stock units
@ $0 |
|
02/01/2023 |
4
| Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.
Txns:
| Granted 302,900 options to buy
@ $12.88, valued at
$3.9M
Granted 107,100 restricted stock units
@ $0 |
|
12/01/2022 |
4
| Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.
Txns:
| Paid exercise price by delivering 3,007 shares
@ $9.95, valued at
$29.9k
|
|
10/03/2022 |
4
| Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.
Txns:
| Paid exercise price by delivering 3,008 shares
@ $12.77, valued at
$38.4k
|
|
09/01/2022 |
4
| Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.
Txns:
| Paid exercise price by delivering 3,007 shares
@ $18.94, valued at
$57k
Sold 20,000 shares
@ $20.0161, valued at
$400.3k
|
|
08/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/31/2022 |
4
| Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.
Txns:
| Paid exercise price by delivering 3,007 shares
@ $6.05, valued at
$18.2k
|
|
03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/31/2022 |
4
| Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.
Txns:
| Paid exercise price by delivering 2,355 shares
@ $7.2, valued at
$17k
|
|
01/03/2022 |
4
| Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.
Txns:
| Paid exercise price by delivering 3,007 shares
@ $8.93, valued at
$26.9k
|
|
12/01/2021 |
4
| Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.
Txns:
| Paid exercise price by delivering 3,007 shares
@ $10.49, valued at
$31.5k
|
|
11/01/2021 |
4
| Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.
Txns:
| Paid exercise price by delivering 3,007 shares
@ $10.8, valued at
$32.5k
|
|
10/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/31/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/02/2021 |
4
| Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.
Txns:
| Paid exercise price by delivering 3,007 shares
@ $9.07, valued at
$27.3k
|
|
07/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/31/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/02/2020 |
4
| Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.
Txns:
| Paid exercise price by delivering 2,243 shares
@ $12.23, valued at
$27.4k
|
|
11/02/2020 |
4
| Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.
Txns:
| Paid exercise price by delivering 2,015 shares
@ $11.45, valued at
$23.1k
|
|
10/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/31/2020 |
4
| Garg Vipin K (President & CEO) has filed a Form 4 on Altimmune, Inc.
Txns:
| Paid exercise price by delivering 2,015 shares
@ $17.62, valued at
$35.5k
|
|
|